|
End-of-day quote
Shenzhen S.E.
22/09/2026
|
5-day change | 1st Jan Change | ||
| 5.910 CNY | -0.17% |
|
+6.10% | -19.81% |
| 08-25 | Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-01 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| Market Cap | 6.07B 906M 792M 744M 679M 1.27B 86.63B 1.28B 8.93B 3.45B 44.24B 3.4B 3.33B 143B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.93B 736M 643M 604M 552M 1.04B 70.35B 1.04B 7.25B 2.8B 35.92B 2.76B 2.7B 116B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.02% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | -0.17% | ||
| 1 week | +6.10% | ||
| Current month | -1.17% | ||
| 1 month | -16.53% | ||
| 3 months | +17.26% | ||
| 6 months | +1.37% | ||
| Current year | -19.81% |
| 1 week | 5.51 |  | 5.99 |
| 1 month | 5.5 | | 7.08 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 10/04/2006 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 10/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 10/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 23/04/2009 |
Yan Ming Qi
CHM | Chairman | 56 | 27/05/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 05/11/25 | Buy | Director | 100 | 0.0000% | ||
| 29/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 28/10/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.17% | +6.10% | -18.71% | -36.72% | 906M | |
| +0.45% | +3.00% | +55.00% | +112.54% | 1,043B | |
| -0.10% | +0.74% | +54.52% | +67.72% | 649B | |
| +0.28% | +0.82% | +19.15% | +73.63% | 469B | |
| -0.19% | +0.17% | +36.92% | +45.50% | 355B | |
| +0.37% | +2.24% | +19.81% | +26.31% | 270B | |
| -1.11% | +3.13% | +11.17% | +11.81% | 262B | |
| +4.34% | +9.21% | +43.44% | +53.25% | 222B | |
| +1.40% | +4.35% | +35.72% | +103.53% | 189B | |
| -0.41% | -5.41% | -31.14% | -59.53% | 175B | |
| Average | +0.38% | +2.59% | +22.59% | +39.80% | 363.39B | |
| Weighted average by Cap. | +0.19% | +2.19% | +36.87% | +66.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 98.57M 86.14M 80.96M 73.88M 139M 9.42B 139M 972M 375M 4.81B 370M 362M 15.51B | 624M 93.08M 81.34M 76.45M 69.77M 131M 8.9B 131M 918M 354M 4.54B 350M 342M 14.65B |
| Net income | -74.07M -11.05M -9.66M -9.08M -8.29M -15.55M -1.06B -15.55M -109M -42.05M -540M -41.51M -40.6M -1.74B | -347M -51.82M -45.29M -42.56M -38.84M -72.9M -4.95B -72.91M -511M -197M -2.53B -195M -190M -8.16B |
| Net Debt | -1.98B -296M -259M -243M -222M -416M -28.28B -416M -2.92B -1.13B -14.44B -1.11B -1.09B -46.56B | -1.14B -170M -149M -140M -128M -240M -16.28B -240M -1.68B -648M -8.32B -640M -626M -26.81B |
Employees
901
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/09/26 | CN¥5.910 | -0.17% | 26,357,154 |
| 21/09/26 | CN¥5.920 | +5.34% | 39,001,328 |
| 18/09/26 | CN¥5.620 | +0.36% | 19,765,752 |
| 17/09/26 | CN¥5.600 | +0.54% | 10,895,050 |
| 16/09/26 | CN¥5.570 | 0.00% | 9,635,900 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
